register | login
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2022 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: Venous thromboembolism

Milvexian phase 2 data supports safety and efficacy for VTE prevention after total knee replacement

Presented By
Prof. Jeffrey Weitz, McMaster University, Canada
Trial
Phase 2, AXIOMATIC-TKR
Conference
AHA 2021

14 January, 2022 13:54

AHA 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
AHA 2021

30 November, 2021 23:20

Rivaroxaban improves clinical outcomes in discharged COVID-19 patients

Presented By
Prof. Eduardo Ramacciotti, Santa Casa School of Medicine, Brasil
Conference
ESC 2021

26 October, 2021 16:40

COVID-19: Thromboembolic risk reduction with therapeutic heparin dosing

Presented By
Prof. Alex Spyropoulos, Northwell Health, USA
Trial
Phase 3, HEP-COVID
Conference
ESC 2021

26 October, 2021 16:34

Haemostatic abnormalities are associated with mortality in COVID-19

Presented By
Dr Yu Hu, Wuhan Union Hospital, China
Conference
EHA 2021

5 August, 2021 15:07

PCSK9 inhibition as primary prevention for VTE: Is it LDL or Lp(a)?

Presented By
Dr Nicholas A. Marston, Women’s Hospital, Boston, USA
Trial
FOURIER, ODYSSEY OUTCOMES, JUPITER
Journal
Physician’s Weekly
Conference
American Heart Association Scientific Sessions 2020

13 April, 2021 18:38

PAD: Rivaroxaban reduces VTE risk after revascularisation

Presented By
Dr Connie Hess; Prof. Judith Hsia
Trial
VOYAGER PAD
Conference
AHA 2020

18 February, 2021 11:45

Similar bleeding rates in patients with VTE and AF treated with DOACs

Presented By
Dr Farès Moustafa, CHU Clermont Ferrand, France
Conference
ISTH 2020

8 September, 2020 16:21

Residual pulmonary obstruction may predict risk of VTE recurrence

Presented By
Dr Robin Chaux, University Hospital St. Etienne, France
Conference
ISTH 2020

8 September, 2020 15:50

Risk of checkpoint inhibitor-associated thromboembolic events important for cancer prognosis

Presented By
Dr Florian Moik, Medical university of Vienna, Austria
Trial
Cohort study
Conference
ISTH 2020

8 September, 2020 15:44

Crosstalk between inflammation and coagulation in severe COVID-19 infections

Presented By
Prof. Roberta Gualtierotti, University of Milan, Italy
Conference
ISTH 2020

8 September, 2020 15:21

COVID-19 associated with higher VTE rates relative to influenza

Presented By
Dr Milou Stals, Leiden University Medical Centre, the Netherlands
Conference
ISTH 2020

8 September, 2020 15:18

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

Presented By
Dr Hanny Al-Samkari, Massachusetts General Hospital, USA
Trial
Cohort study
Conference
ISTH 2020

8 September, 2020 15:15

COVID-19 not associated with heightened VTE risk after discharge

Presented By
Dr Matthias Engelen, University Hospital Leuven, Belgium
Conference
ISTH 2020

8 September, 2020 15:09

Lower embryopathy risk with DOAC versus VKA during pregnancy

Presented By
Dr Jan Beyer-Westendorf, UNI-Klinikum Carl Gustav Carus Medizinische Klinik I, Germany
Conference
ISTH 2020

8 September, 2020 14:53

Higher thrombotic risk in NSCLC patient with ALK rearrangement

Presented By
Dr Hanny Al-Samkari, Massachusetts General Hospital, USA
Conference
ISTH 2020

8 September, 2020 14:41

Apixaban offers new perspective for cancer patients in need of anticoagulation

Presented By
Prof. G. Agnelli, University of Perugia, Italy
Trial
Phase 3, CARAVAGGIO
Conference
ACC 2020

7 September, 2020 23:13

Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery

Presented By
Prof. N. Rosencher, Paris Center University Hospital, France
Trial
PRONOMOS
Conference
ACC 2020

7 September, 2020 23:07

Higher mortality risk with tramadol versus NSAIDs for osteoarthritis patients

Presented By
Lingyi Li, University of British Columbia, Canada
Conference
EULAR 2020

14 August, 2020 14:37

Rivaroxaban is safe and effective for paediatric venous thromboembolism

Presented By
Prof. Guy Young, Children's Hospital Los Angeles, USA
Trial
Phase 3, EINSTEIN-Jr
Conference
ASH 2019

5 March, 2020 20:19

Aspirin plus DOAC is not better than a DOAC alone

Presented By
Prof. Jordan Schaefer, University of Michigan, USA
Conference
ASH 2019

5 March, 2020 19:23

Apixaban is safe and effective in real-world setting for treatment of venous thromboembolism

Conference
ACC 2019

6 June, 2019 12:17
site created by:   

© 2021 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT